STOCK TITAN

Thermo Fisher (NYSE: TMO) director receives 499-share stock award

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

JOHNSON JENNIFER M reported acquisition or exercise transactions in this Form 4 filing.

Thermo Fisher Scientific director Jennifer M. Johnson reported receiving a grant of 499 shares of Common Stock on May 20, 2026. The award was recorded at a price of $0.00 per share, indicating it was part of her director compensation rather than an open-market purchase. After this grant, she directly holds a total of 1,403 shares of Thermo Fisher Scientific common stock.

Positive

  • None.

Negative

  • None.
Insider JOHNSON JENNIFER M
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 499 $0.00 $0.00
Holdings After Transaction: Common Stock — 1,403 shares (Direct)
Shares granted 499 shares Common Stock grant on May 20, 2026
Grant price $0.00 per share Recorded transaction price for the award
Shares held after transaction 1,403 shares Direct holdings following the grant
Transaction code A Grant, award, or other acquisition of Common Stock
Ownership type Direct Direct ownership of awarded shares
Grant, award, or other acquisition financial
"transaction code description is “Grant, award, or other acquisition”"
Common Stock financial
"security_title field identifies the security as Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
non-derivative financial
"transaction_type is listed as non-derivative"
transaction code A financial
"transaction_code is A, indicating a grant or award"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Thermo Fisher (TMO) director Jennifer M. Johnson report?

Jennifer M. Johnson reported receiving a grant of 499 shares of Thermo Fisher Scientific Common Stock. The grant was recorded at $0.00 per share, reflecting stock-based compensation rather than an open-market purchase, and increased her direct holdings to 1,403 shares.

Was the Thermo Fisher (TMO) insider transaction a stock purchase or a grant?

The transaction was a grant or award, not an open-market purchase. The Form 4 shows transaction code A, described as a “Grant, award, or other acquisition,” with 499 shares acquired at $0.00 per share as director compensation.

How many Thermo Fisher (TMO) shares does Jennifer M. Johnson hold after this Form 4?

Following the reported grant, Jennifer M. Johnson directly holds 1,403 shares of Thermo Fisher Scientific Common Stock. This total includes the newly awarded 499 shares reported in the Form 4 transaction dated May 20, 2026.

What does transaction code A mean in the Thermo Fisher (TMO) Form 4 filing?

Transaction code A indicates a grant, award, or other acquisition of securities, typically as compensation. In this case, it reflects 499 shares of Thermo Fisher Scientific Common Stock awarded to director Jennifer M. Johnson, rather than shares bought on the open market.

Did the Thermo Fisher (TMO) director pay for the 499-share award reported on Form 4?

The filing shows a transaction price of $0.00 per share for the 499-share award. This indicates the shares were granted as part of equity compensation, with no cash paid by director Jennifer M. Johnson for the acquisition.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOHNSON JENNIFER M

(Last)(First)(Middle)
168 THIRD AVENUE

(Street)
WALTHAM MASSACHUSETTS 02451

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026A499A$01,403D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
Reporting Person is the Chief Executive Officer and a Director of Franklin Resources, Inc., a global investment management organization operating as Franklin Templeton?. Franklin Templeton subsidiaries manage investment products and client accounts that hold equity securities of the Issuer in the ordinary course of business. Reporting Person disclaims beneficial ownership of such securities.
/s/ Melodie T. Morin, Attorney-in-Fact for Jennifer M. Johnson05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)